677 related articles for article (PubMed ID: 23228653)
1. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
Charerntantanakul W; Pongjaroenkit S
Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
[TBL] [Abstract][Full Text] [Related]
4. Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region.
Stadler J; Naderer L; Beffort L; Ritzmann M; Emrich D; Hermanns W; Fiebig K; Saalmüller A; Gerner W; Glatthaar-Saalmüller B; Ladinig A
PLoS One; 2018; 13(9):e0203560. PubMed ID: 30192831
[TBL] [Abstract][Full Text] [Related]
5. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
[TBL] [Abstract][Full Text] [Related]
6. Effect of vaccination route (intradermal vs. intramuscular) against porcine reproductive and respiratory syndrome using a modified live vaccine on systemic and mucosal immune response and virus transmission in pigs.
Renson P; Mahé S; Andraud M; Le Dimna M; Paboeuf F; Rose N; Bourry O
BMC Vet Res; 2024 Jan; 20(1):5. PubMed ID: 38172908
[TBL] [Abstract][Full Text] [Related]
7. Immunological response to porcine reproductive and respiratory syndrome virus in young pigs obtained from a PRRSV-positive exposure status herd in a PRRSV endemic area.
Kittiwan N; Yamsakul P; Tadee P; Tadee P; Nuangmek A; Chuammitri P; Patchanee P
Vet Immunol Immunopathol; 2019 Dec; 218():109935. PubMed ID: 31562984
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant danger signals increase the immune response to porcine reproductive and respiratory syndrome virus.
Foss DL; Zilliox MJ; Meier W; Zuckermann F; Murtaugh MP
Viral Immunol; 2002; 15(4):557-66. PubMed ID: 12513927
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Porcine Interferon Alpha Enhances Immune Responses to Killed Porcine Reproductive and Respiratory Syndrome Virus Vaccine in Pigs.
Yu HY; Qu MS; Zhang JL; Gan L; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
Viral Immunol; 2019 Nov; 32(9):383-392. PubMed ID: 31693458
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions.
Jeong J; Kim S; Park KH; Kang I; Park SJ; Yang S; Oh T; Chae C
Vet Microbiol; 2018 Feb; 214():113-124. PubMed ID: 29408022
[TBL] [Abstract][Full Text] [Related]
12. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
[TBL] [Abstract][Full Text] [Related]
13. Effects of a modified-live virus vaccine against porcine reproductive and respiratory syndrome in boars.
Christopher-Hennings J; Nelson EA; Nelson JK; Benfield DA
Am J Vet Res; 1997 Jan; 58(1):40-5. PubMed ID: 8989494
[TBL] [Abstract][Full Text] [Related]
14. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
[TBL] [Abstract][Full Text] [Related]
15. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
Yang S; Oh T; Cho H; Chae C
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and characteristics of immunological adjuvant activity of purified fraction of Albizia julibrissin saponins.
Zhu B; He T; Gao X; Shi M; Sun H
Immunol Invest; 2019 Apr; 48(3):283-302. PubMed ID: 30325683
[TBL] [Abstract][Full Text] [Related]
17. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2.
Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C
J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631
[TBL] [Abstract][Full Text] [Related]
18. A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNγ responses against several genotype 2 strains.
Cui J; O'Connell CM; Costa A; Pan Y; Smyth JA; Verardi PH; Burgess DJ; Van Kruiningen HJ; Garmendia AE
PLoS One; 2019; 14(1):e0208801. PubMed ID: 30703122
[TBL] [Abstract][Full Text] [Related]
19. Nasal delivery of chitosan/alginate nanoparticle encapsulated bee (Apis mellifera) venom promotes antibody production and viral clearance during porcine reproductive and respiratory syndrome virus infection by modulating T cell related responses.
Lee J; Kim YM; Kim JH; Cho CW; Jeon JW; Park JK; Lee SH; Jung BG; Lee BJ
Vet Immunol Immunopathol; 2018 Jun; 200():40-51. PubMed ID: 29776611
[TBL] [Abstract][Full Text] [Related]
20. Immune response development after vaccination of 1-day-old naïve pigs with a Porcine Reproductive and Respiratory Syndrome 1-based modified live virus vaccine.
Balasch M; Fort M; Taylor LP; Díaz I; Mateu E; Calvert JG
Porcine Health Manag; 2019; 5():2. PubMed ID: 30761215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
